Companies To Watch

Companies To Watch: Corner Therapeutics

Corner Therapeutics is focused on discovering new small molecules that could mimic the body’s natural immune response to generate the robust T-cell response.

Companies To Watch: Ocelot Bio

Ocelot Bio is focusing a single drug on multiple complications of end-stage liver disease.

Companies To Watch: iTolerance

iTolerance is dedicated to curing diabetes and other conditions by inducing local immune tolerance in implantation.

Companies To Watch: CytoAgents

CytoAgents is combatting the broad areas of disease stemming from a common cause: cytokine release syndrome.

Companies To Watch: Viking Therapeutics

Viking Therapeutics is a broad-target contender for treating NASH in a pipeline of new drugs for metabolic and endocrine disorders.

Companies To Watch: Priothera

Priothera is bent on boosting the safety and effectiveness of hematopoietic stem cell transplantation for blood cancers.

Companies To Watch: Mirum Pharmaceuticals

Mirum Pharmaceuticals: Two drugs, one FDA approved, together taking on a half-dozen rare liver diseases.

Companies To Watch: CinCor Pharma

CinCor Pharma is uncovering a great potential for combatting treatment-resistant and uncontrolled hypertension.

Companies To Watch: Castle Creek Biosciences

For Castle Creek Biosciences, there are many stakes at play in targeting rare skin, connective tissue, liver, and metabolic disorders.

Companies To Watch: Global Blood Therapeutics

Global Blood Therapeutics is intertwining science, business, and social missions to make progress against sickle cell disease.

Companies To Watch: Endevica Bio

Endevica Bio is developing a new treatment for cachexia, a severe wasting disease critical to patients’ survival in cancer and other conditions.

Companies To Watch: MiroBio

MiroBio is precisely targeting checkpoint receptors with agonist antibodies for better treatments in autoimmunity.

Companies To Watch: Qlaris Bio

Qlaris Bio is striking at an unaddressed target in the intraocular pressure of glaucoma.

Companies To Watch: Graphite Bio

Graphite Bio focuses on precise repair of genes that cause sickness, starting with Sickle Cell Disease.